Brains Bioceutical

The Brains Pure #MadeBetter series is a community of inspiring people sharing stories of how nature has made their lives better. Our roots lie in nature, the place where exceptional is found. Featuring Liam Yates, Wild Swim Girls, Gulf Stream Surfboards, and Carmen Pie 🌿⛰

Brains Bioceutical has been granted a Certificate of Suitability (CEP) by the EDQM for our pharmaceutical-grade CBD, confirming our naturally-derived ingredient meets European Pharmacopoeia standards. The CEP adds to what is now the most comprehensive regulatory credential portfolio for a naturally-derived CBD pharmaceutical ingredient, positioning us as the premier supplier for drug developers in EU and Ph. Eur.-aligned markets. Read more: apnews.com/press-release/…

Brains Bio is proud to support @pacificautism 7th Annual LAUNCH Holiday Luncheon. This event brings together leaders who are creating meaningful support for neurodiverse individuals and their families. We are honoured to stand behind a cause that reflects our commitment to community, compassion, and real impact. #PAFNLaunch #PAFN

Great to be at the heart of pharma innovation here at CPHI Frankfurt — connecting with global leaders, partners, and new collaborators driving the future of medicine. Looking forward to Day 2 at booth 12.1D128.

Great to see @GaryBrecka highlighting the science behind hemp-derived CBD and the endocannabinoid system. At Brains Bio, we’ve been advancing this research globally from our EU-GMP-certified APIs to clinical programs improving sleep, pain, and mood. The science is catching up with what nature already knew. 🌿 #madebetter

By describing cannabinoids as medicine, @realDonaldTrump has reframed the entire conversation. APIs — not consumer-grade oils or unregulated supplements — will be the foundation of this market. With clinical validation, regulatory filings, and global-scale production, Brains Bioceutical is uniquely positioned to lead this transformation. apnews.com/press-release/…

@Forbes spotlights Brains Bioceutical CEO & Chairman Ricky Brar — the farmer-turned-biotech leader transforming plant-based pharmaceuticals with EU-GMP certified cannabinoid APIs powering clinical trials and global partnerships. forbesscotland.com/from-agricultu…

As a leader in the Canadian, Punjabi, and Indian communities, Ricky has worked to create opportunities for people from all backgrounds. This honour is a testament to his dedication to making a lasting impact. Congratulations, Ricky, on this well-earned recognition!

Beyond business, he has helped over 200 families immigrate to Canada, founded medical patient associations in multiple countries, and supported numerous charities and community programs.

Congratulations to our CEO & Chairman, Ricky Brar, on receiving the King Charles III Coronation Medal—an honour recognizing leadership, innovation, and lasting impact.

"This is a defining moment for Brains Bio and the industry,"said Rick Brar, CEO & Chairman of Brains Bio. "Consumers demand purity, consistency, and safety, and this approval validates our commitment to delivering pharmaceutical-grade, natural CBD." newswire.ca/news-releases/…

“The introduction of high-quality CBN API, D9 THC and CBG is a landmark moment for Brains Bio, and for the entire pharmaceutical industry,” financialpost.com/globe-newswire…

Join us at #CPHIWorldwide2024 to discuss our strategic partnerships and explore how our cannabinoid-based APIs can support your development needs. Schedule a meeting with us at lnkd.in/gv3C9Bk5 Learn more about our pioneering API offerings at brainsbio.com.

Brains Bioceutical Set to Achieve One of the World's First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare nationalpost.com/globe-newswire…

We are thrilled to share that DSM-Firmenich has launched an advanced formulated CBD drug product intermediate, CBTru®, using Brains Bio's EU GMP certified CBD API. This milestone elevates patient health and marks a new era in the pharmaceutical cannabinoid industry. Our EU GMP certified CBD API ensures the highest standards of safety and efficacy, enabling DSM-Firmenich to develop a solution that will make a real difference in patients' lives. #PharmaceuticalInnovation #CBD #Healthcare #BrainsBio #DSM #EUgmp #DrugDevelopment #PatientHealth #InnovationInMedicine lnkd.in/gRqEpner

Fantastic wrap-up at #InternationalCBC! 🌿 We’re propelling #cannabinoid science & patient support forward. With EU-GMP ingredients, patient-first formats & uncompromised pharma standards, the full potential of cannabinoids is within reach. @dsmfirmenich & Brains Bio continue to lead the way in this rigorous, science-driven journey! 💪 #cannabinoidscience

Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp's Solid THC Paves the Way for Revolutionary Drug Development for the pharmaceutical industry. #MadeBetter finance.yahoo.com/news/brains-bi…

Not long now until the 6th Annual Cannabinoid-Derived Drug Development Summit! We’re ready to discuss everything from translation, bioavailability, dosage, delivery and much more! @dsmfirmenich Innovation Manager Alexandru Zabara and @BrainsBio Senior Vice President @B_Bhullar are also thrilled to be leading the plenary keynote session on the first day of the conference. Join us there or at our booth for some exclusive insights from the experts themselves, as well as our partner in #cannabinoid #APIs @dsmfirmenich It's not too late to join us! Register here: bit.ly/45AXBSb #cannabinoids #cannabidiol #APIs #pharmaceuticals